Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Kashiwa
Clinical trial register · Japan

Clinical Trials in Kashiwa, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2493 matching records held by the registry are in this view. Synced 22 Oct 2026, 03:19 UTC
2493
Studies in scope
all four open statuses
1263
Recruiting now
open to new participants
349
Lead sponsors
across recruiting studies
Top sites
Chūōku 37 Fukuoka 33 Bunkyō City 20 Chiba 19 Nagoya 19
Narrow the registerReset
Recruitment status
Phase
Site location
Chūōku37 Fukuoka33 Bunkyō City20 Chiba19 Nagoya19
All 194 locations
Target enrolment
to

Trials with a site in Kashiwa

18 of 2493 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
Eli Lilly and Company
Phase 2
1,431
Asahikawa, Bunkyō City, Fujiidera, Fukuoka, Hirosaki, Kagoshima, Kashiwa, Mitaka
2026-03-26
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
Eli Lilly and Company
Phase 3
450
Chūōku, Fukuoka, Hirosaki, Kanazawa, Kashiwa, Kawasaki, Kita-ku, Kobe
2025-12-12
Recruiting
Eli Lilly and Company
Phase 2
252
Fukuoka, Kamakura, Kashiwa, Osaka, Sakura, Sapporo
2025-11-10
Recruiting
Eli Lilly and Company
Phase 3
1,630
Akashi, Chūōku, Fukuoka, Hidaka, Kagoshima, Kashiwa, Kōtoku, Nagoya
2025-10-22
Recruiting
Eli Lilly and Company
Phase 3
700
Bunkyō City, Fukuoka, Hidaka, Himeji, Hirakata, Kanazawa, Kashiwa, Kōtō City
2025-03-27
Recruiting
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
NCT06561685Metastatic Solid Tumor, Advanced Solid Tumor, Non-small Cell Lung Cancer, SMARCA4-Deficient Tumor
Eli Lilly and Company
Phase 1
340
Chūōku, Kashiwa, Kōtō City, Nagaizumi-cho,Sunto-gun, Nagoya
2024-09-19
Active, closed
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
NCT06238479Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor, Urinary Bladder Neoplasm
Eli Lilly and Company
Phase 1
490
Chūōku, Kashiwa, Kōtō City, Kyoto
2024-03-05
Active, closed
Eli Lilly and Company
Phase 3
925
Nagoya, Kashiwa, Kisarazu, Sakura, Sapporo, Kobe, Kanazawa, Kita
2022-04-14
Active, closed
Eli Lilly and Company
Phase 3
152
Nagoya, Kashiwa, Himeji, Yokohama, Niigata, Nakatogari, Koto, Yonago
2021-12-20
Active, closed
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
NCT04956640Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Endometrial Neoplasms, Ovarian Neoplasms
Eli Lilly and Company
Phase 1/2
540
Nagoya, Kashiwa, Sapporo, Kanazawa, Chuo-ku, Wakayama
2021-07-19
Recruiting
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
NCT04844606Ulcerative Colitis, Ulcerative Colitis Chronic, Inflammatory Bowel Diseases, Crohn's Disease
Eli Lilly and Company
Phase 3
150
Bunkyō, Bunkyō City, Kashiwa, Kobe, Tokyo, Yokohama
2021-05-26
Active, closed
Eli Lilly and Company
Phase 1
200
Kashiwa, Yokohama, Suita-shi, Nakatogari, Chuo-ku
2020-10-01
Active, closed
Eli Lilly and Company
Phase 3
996
Hirosaki, Kashiwa, Kitakyusyu-shi, Chikushino-shi, Fukuoka, Kiryū, Chuo-ku, Sapporo-shi, Sapporo
2020-06-22
Active, closed
Eli Lilly and Company
Phase 3
261
Kashiwa, Sapporo, Kanazawa, Yokohama, Osaka Sayama-shi, Nakatogari, Chuo-ku, Koto
2020-02-17
Active, closed
Eli Lilly and Company
Phase 3
5,637
Nagoya, Chiba, Kashiwa, Matsuyama, Kurume, Ōta, Hiroshima, Sapporo
2017-07-12
Active, closed
Eli Lilly and Company
Phase 1/2
857
Nagoya, Kashiwa, Sapporo, Akashi, Kanazawa, Osaka Sayama-shi, Nagaizumi-cho,Sunto-gun, Chuo-ku
2017-05-02
Active, closed
Eli Lilly and Company
Phase 3
545
Nagoya, Kashiwa, Tōon, Kurume, Asahikawa, Akashi, Amagashiki, Himeji
2015-05-06
Active, closed
Eli Lilly and Company
Phase 3
669
Nagoya, Chiba, Kashiwa, Matsuyama, Kurume, Sapporo, Nishinomiya, Kawasaki
2014-07-22
Rows per page Showing 1–18 of 18
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 October 2026. https://priyalifescience.com/clinical-trials-japan/city/kashiwa

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,493 studies in total at the last sync on 22 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 18 of those studies with a site in Kashiwa that also match the filters currently applied.

How many clinical trials are recruiting in Kashiwa?

7 of the 18 studies on this page are recruiting new participants as of the 22 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 11 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Kashiwa), 18 studies
PhaseStudiesRecruitingShare
Phase 311461.1%
Phase 13116.7%
Phase 1/22011.1%
Phase 22211.1%

Most active sponsors

Lead sponsors with the most studies (Kashiwa)
Lead sponsorStudiesRecruiting
Eli Lilly and Company187
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.